Interstitial Lung Disease Archives

United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA

Published on : April 19, 2021April 19, 2021 Published by : BioBuzz Media

United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a [….]

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Published on : April 1, 2021April 1, 2021 Published by : BioBuzz Media

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease